CLINICAL_TRIALS
trial_result
· 2012-11-01
Clinical Trial Update: A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Summary
Phase 3 trial evaluating LAS34273 in moderate to severe stable COPD has completed. Results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: COMPLETED | Results posted: 2012-11-01